[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Matsubara et al., 2010 - Google Patents

Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy

Matsubara et al., 2010

Document ID
14300317224603975213
Author
Matsubara T
Onishi A
Saito T
Shimada A
Inoue H
Taki T
Nagata K
Okahata Y
Sato T
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Influenza is an infectious disease caused by the influenza virus, and each year many people suffer from this disease. Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglycoconjugate receptors on the host cell surface at an initial step in the …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
    • C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Similar Documents

Publication Publication Date Title
Matsubara et al. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy
Waldmann et al. A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza
Liao et al. Differential receptor binding affinities of influenza hemagglutinins on glycan arrays
Di Iorio et al. Weak multivalent binding of influenza hemagglutinin nanoparticles at a sialoglycan-functionalized supported lipid bilayer
Sato et al. High mannose-binding lectin with preference for the cluster of α1–2-mannose from the green alga Boodlea coacta is a potent entry inhibitor of HIV-1 and influenza viruses
Gamblin et al. Hemagglutinin structure and activities
Stevens et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities
Wu et al. Influenza A surface glycosylation and vaccine design
Ströh et al. Glycan engagement by viruses: receptor switches and specificity
Pan et al. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo
AU2013207641B2 (en) Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
CN102037013B (en) Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes
Choi et al. DNA aptamers against the receptor binding region of hemagglutinin prevent avian influenza viral infection
Zhang et al. Optimization of N-substituted oseltamivir derivatives as potent inhibitors of group-1 and-2 influenza A neuraminidases, including a drug-resistant variant
Deng et al. Exploration of sialic acid diversity and biology using sialoglycan microarrays
US20100074920A1 (en) Peptide vaccine for influenza virus
Li et al. Inhibitors targeting the influenza virus hemagglutinin
Lu et al. Enhanced inhibition of influenza A virus adhesion by di-and trivalent hemagglutinin inhibitors
Ng et al. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus
US20100285982A1 (en) Immunogenic peptides of influenza virus
Hatano et al. Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding Peptide
Andersson et al. Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein
KR102122618B1 (en) Agents for influenza neutralization
KR20140112495A (en) Influenza a virus specific antibodies
Umemura et al. Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection